WASHINGTON (AP) — U.S. regulators have greenlighted a new weight-loss drug called Contrave, the third in a string of approvals for prescription medications aimed at the nation’s 78 million obese adults.
The pill, Contrave, is a combination of two drugs that are already approved, naltrexone and bupropion.
